Medidata RTSM
Studies change. Your randomization and trial supply management (RTSM) system shouldn't slow you down.
Medidata RTSM connects randomization, patient assignment, and drug logistics in one unified environment on the Medidata Platform. Apply protocol updates, manage inventory, and maintain real-time oversight without losing momentum.
Execution at Global Scale
Sponsors and sites can’t afford silos between randomization, supply, and reporting in global trials.
Medidata RTSM brings these workflows together, giving teams visibility, a better user experience, and more control. Reach First Patient In (FPI) faster, adapt to mid-study changes, and stay on track for milestones.
Reach FPI Faster
Adapt without Disruption
Gain End-to-end Study Visibility
Work in One Unified Experience
Proven at Scale
Leverage Expert Professional Services
Proven at Scale
Control across Start-up, Change, and Supply
Faster Study Launch
Configure Complex Trials without Unnecessary Rework
RTSM supports simple to highly complex randomization and supply strategies within one system, reducing configuration cycles and enabling faster progression to First Patient In.
Download Fact Sheet
Real-world Results across Programs
After 30 years in Pharmaceutical Supply Chain, I have found Medidata RTSM to be the most complete and user-friendly IRT system to support clinical supplies.
Todd Zegarzewski
Senior Supply Chain Manager
Medidata RTSM and the RTSM PS team complemented each other perfectly in our study. Especially in complex studies with different study materials, Medidata RTSM is extremely helpful in maintaining an overview at all times.
Dr. Bernd Ullrich
Senior Clinical Trial Manager
Medidata’s comprehensive suite of services has simplified aspects of the clinical trial process, from randomization to data collection and analysis…our research teams were able to confidently navigate the complexities of the trial to ensure all data elements were captured efficiently.
Jenna Brager PhD
RN, Executive VP, Drug Development
FAQ
Can Medidata RTSM handle mid-study changes without downtime?
Yes. Medidata RTSM allows for mid-study changes, such as protocol updates or adding new cohorts, with no downtime. Its "Edit Live Design" capability enables study builders to apply changes in real-time without stopping enrollment or requiring change orders, ensuring that the trial remains on track.
How does Medidata RTSM integration with Rave EDC benefit the study?
Medidata RTSM is fully unified with Rave EDC on the Medidata Platform, meaning it's not a separate integration but part of the same system. This unification eliminates the need for double data entry and reconciliation between randomization and EDC systems, significantly reducing data integrity risks and accelerating timelines from study start-up to database lock.
Does the system support direct-to-patient (DtP) supply management?
Yes. Medidata RTSM features robust direct-to-patient capabilities that support decentralized and hybrid trials. It allows shipments to be triggered at the site, visit, or patient level, and patients can confirm receipt of investigational product (IP) directly through their myMedidata account.
Is Medidata RTSM suitable for complex trial designs?
Yes. The solution is designed to handle everything from simple to highly complex trial designs, including adaptive trials and those requiring robust cohort management. It supports complex randomization and dosing scenarios, such as multi-dose vial tracking and pooling inventory across studies to maximize efficiency.
Does Medidata offer training for its clients and partners?
Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.